Tranexamic Acid Per Inhalation for Treatment of Pulmonary Hemorrhage in Pediatric Patients

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

February 1, 2020

Study Completion Date

May 1, 2020

Conditions

Pulmonary HemorrhageMAPCA - Major Aortopulmonary Collateral Artery

Interventions

DRUG

Tranexamic Acid

Inhalation of Transexamic acid in age adjusted dosing

Trial Locations (1)

Texas Children's Hospital, Houston

All Listed Sponsors

lead

Baylor College of Medicine

OTHER

NCT03676023 - Tranexamic Acid Per Inhalation for Treatment of Pulmonary Hemorrhage in Pediatric Patients | Biotech Hunter | Biotech Hunter